{
    "organizations": [],
    "uuid": "b26ed0b3aff17ec6f9ada7e4c7cc77ef2d475e03",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-inventionmed-publishes-development/brief-inventionmed-publishes-development-strategy-for-years-2018-2021-idUSFWN1QD0EC",
    "ord_in_thread": 0,
    "title": "BRIEF-Inventionmed Publishes Development Strategy For Years 2018-2021",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 23 (Reuters) - INVENTIONMED SA:\n* PUBLISHES ITS DEVELOPMENT STRATEGY FOR YEARS 2018-2021\n* PLANS TO FOCUS ON DEVELOPMENT OF ADVANCED MEDICAL SIMULATORS USING VIRTUAL REALITY TECHNOLOGY\n* ESTIMATES ITS CAPEX FOR STRATEGY REALIZATION WILL AMOUNT IN TOTAL 8 MILLION ZLOTYS TILL 2021\n* PLANS FIRST PILOT STUDIES OF ITS MEDICAL SIMULATOR ‘TUTORDERM’ IN Q4 2018\n* PLANS TO PUT ‘TUTORDERM’ ON SALE IN Q1 2020 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-23T15:49:00.000+02:00",
    "crawled": "2018-02-24T13:37:33.009+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "inventionmed",
        "sa",
        "publishes",
        "development",
        "strategy",
        "year",
        "plan",
        "focus",
        "development",
        "advanced",
        "medical",
        "simulator",
        "using",
        "virtual",
        "reality",
        "technology",
        "estimate",
        "capex",
        "strategy",
        "realization",
        "amount",
        "total",
        "million",
        "zloty",
        "till",
        "plan",
        "first",
        "pilot",
        "study",
        "medical",
        "simulator",
        "tutorderm",
        "q4",
        "plan",
        "put",
        "tutorderm",
        "sale",
        "q1",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}